These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10982067)

  • 1. Prevention of secondary cases of meningococcal disease in Denmark.
    Samuelsson S; Hansen ET; Osler M; Jeune B
    Epidemiol Infect; 2000 Jun; 124(3):433-40. PubMed ID: 10982067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary cases of meningococcal infection among close family and household contacts in England and Wales, 1984-7.
    Cooke RP; Riordan T; Jones DM; Painter MJ
    BMJ; 1989 Mar; 298(6673):555-8. PubMed ID: 2495111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of vaccinating household contacts in addition to chemoprophylaxis after a case of meningococcal disease: a systematic review.
    Hoek MR; Christensen H; Hellenbrand W; Stefanoff P; Howitz M; Stuart JM
    Epidemiol Infect; 2008 Nov; 136(11):1441-7. PubMed ID: 18559124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of secondary cases of meningococcal disease in household contacts by vaccination.
    Greenwood BM; Hassan-King M; Whittle HC
    Br Med J; 1978 May; 1(6123):1317-9. PubMed ID: 417754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variations in chemoprophylaxis for meningococcal disease: a retrospective case note review, analysis of routine prescribing data and questionnaire of general practitioners.
    Marks PJ; Neal KR
    BMC Public Health; 2001; 1():16. PubMed ID: 11806758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Policy for the prevention of meningococcal infections in Belgium].
    De Wals P
    Rev Epidemiol Sante Publique; 1983; 31(3):273-82. PubMed ID: 6658101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A retrospective survey of clusters of meningococcal disease in England and Wales, 1993 to 1995: estimated risks of further cases in household and educational settings.
    Hastings L; Stuart J; Andrews N; Begg N
    Commun Dis Rep CDR Rev; 1997 Dec; 7(13):R195-200. PubMed ID: 9447784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Meningococcal vaccines. Global epidemiological situation and strategies for prevention by vaccination].
    Rivero Calle I; Rodriguez-Tenreiro Sánchez C; Martinón-Torres F
    Enferm Infecc Microbiol Clin; 2015 Apr; 33(4):257-67. PubMed ID: 25795150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survey of the prescribing of chemoprophylaxis to index cases of invasive meningococcal disease.
    Heywood P; Holtby I
    Commun Dis Public Health; 2000 Dec; 3(4):271-3. PubMed ID: 11280257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meningococcal disease in siblings caused by rifampicin sensitive and rifampicin resistant strains.
    Dawson SJ; Fey RE; McNulty CA
    Commun Dis Public Health; 1999 Sep; 2(3):215-6. PubMed ID: 10491880
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An epidemic of meningococcal infection at Zaria, Northern Nigeria. 3. Meningococcal carriage.
    Hassan-King M; Greenwood BM; Whittle HC; Abbott JD; Sutcliffe EM
    Trans R Soc Trop Med Hyg; 1979; 73(5):567-73. PubMed ID: 531911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention of secondary cases of invasive meningococcal infection: role of chemoprophylaxis and vaccination].
    Chuard C; Regamey C
    Rev Med Suisse Romande; 2003 Mar; 123(3):151-4. PubMed ID: 15095699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of antibiotics in preventing meningococcal disease after a case: systematic review.
    Purcell B; Samuelsson S; Hahné SJ; Ehrhard I; Heuberger S; Camaroni I; Charlett A; Stuart JM
    BMJ; 2004 Jun; 328(7452):1339. PubMed ID: 15178612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary meningococcal conjunctivitis: Summary of evidence for the clinical and public health management of cases and close contacts.
    Parikh SR; Campbell H; Mandal S; Ramsay ME; Ladhani SN
    J Infect; 2019 Dec; 79(6):490-494. PubMed ID: 31669376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Public health considerations in the management of meningococcal disease.
    McCormick JB; Bennett JV
    Ann Intern Med; 1975 Dec; 83(6):883-6. PubMed ID: 1106287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meningococcal disease in California. Epidemiology and management.
    Juels C; Morrison FR; Overturf GD; Roberto RR; Chin JC
    West J Med; 1978 Mar; 128(3):195-202. PubMed ID: 636408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Secondary cases of meningococcal disease in The Netherlands, 1989-1990; a reappraisal of chemoprophylaxis].
    Scholten RJ; Bijlmer HA; Dankert J; Valkenburg HA
    Ned Tijdschr Geneeskd; 1993 Jul; 137(30):1505-8. PubMed ID: 8366938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.
    Samuelsson S; Ege P; Berthelsen L; Lind I
    Epidemiol Infect; 1992 Feb; 108(1):19-30. PubMed ID: 1547836
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, placebo-controlled trial of erythromycin estolate chemoprophylaxis for household contacts of children with culture-positive bordetella pertussis infection.
    Halperin SA; Bortolussi R; Langley JM; Eastwood BJ; De Serres G
    Pediatrics; 1999 Oct; 104(4):e42. PubMed ID: 10506267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meningococcal disease prevention and control strategies for practice-based physicians. Committee on Infectious Diseases, American Academy of Pediatrics. Infectious Diseases and Immunization Committee, Canadian Paediatric Society.
    Pediatrics; 1996 Mar; 97(3):404-12. PubMed ID: 8604281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.